The Multilevel Dimension of Rules-Based Disease Surveillance beyond the State

Villarreal, Pedro A.

doi:10.1163/15718093-bja10070

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

The Multilevel Dimension of Rules-Based Disease Surveillance beyond the State

MPS-Authors

/persons/resource/persons236895

Villarreal, Pedro A.
Max Planck Institute for Comparative Public Law and International Law, Max Planck Society;

External Resource

https://doi.org/10.1163/15718093-bja10070
(出版社版)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

EJHL_2022_Villarreal_2.pdf
(出版社版), 2MB

付随資料 (公開)

There is no public supplementary material available

引用

Villarreal, P. A. (2022). The Multilevel Dimension of Rules-Based Disease Surveillance beyond the State. European Journal of Health Law, 29(1), 7-32. doi:10.1163/15718093-bja10070.

引用: https://hdl.handle.net/21.11116/0000-000F-7872-A

要旨

The timely availability of accurate information on disease outbreaks with a potential for cross-border spread is a global public good, allowing for a more effective preparedness and response. An ensuing question for national public health authorities is how such information is attained when it is gathered in territories beyond their jurisdiction. International and regional law norms emerge as an option for providing such a global public good. Therefore, the current article examines existing legal frameworks for ad hoc disease surveillance beyond the state at the international and regional levels, namely: the World Health Organization’s International Health Regulations of 2005; Regulation (EC) No. 851/2004 and Decision No. 1082/2013/EU in the European Union; the Statute of the Africa Centres for Disease Control and Prevention within the African Union; and the Protocol from the Economic Community of West African States, which created the West African Health Organisation. The comparison offers broader insights on the role of rules as a vehicle for securing prompt and reliable information of new and re-emerging communicable diseases, such as Covid-19.